Rrp Semiconductor Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of RRP Semiconductor Ltd is ₹ 8044 as of 12 Oct 15:30 . The P/E Ratio of RRP Semiconductor Ltd changed from 99.4 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of RRP Semiconductor Ltd changed from ₹ 841.35 crore on March 2025 to ₹ 13264 crore on March 2026 . This represents a CAGR of 297.07% over 2 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of RRP Semiconductor Ltd for the Jun '26 is ₹ 0.02 crore as compare to the Mar '26 revenue of ₹ 0.03 crore. This represent the decline of -33.33% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of RRP Semiconductor Ltd for the Jun '26 is ₹ -0.04 crore as compare to the Mar '26 ebitda of ₹ -0.11 crore. This represent the decline of -63.64% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of RRP Semiconductor Ltd changed from ₹ 1.68 crore to ₹ -0.33 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of RRP Semiconductor Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About RRP Semiconductor Ltd

RRP Semiconductor Ltd Share Price Overview RRP Semiconductor share price history shows how the stock has moved across different market phases over time.
The company operates in the semiconductor and electronics distribution space, supplying components and related products to industrial and technology-focused customers.
The stock price mainly changes with electronics demand, global semiconductor trends, and investor outlook on India’s growing technology and manufacturing sector.   This price history helps investors understand how the stock reacts to quarterly earnings, shifts in industry demand, supply chain changes, and other key company events.
Studying these patterns supports more confident decisions and reduces reliance on short-term market movements. Long‑Term Performance Over the years, RRP Semiconductor Ltd share price has shown a strong upward trend across different market cycles.
The stock has delivered around 1446% CAGR over the last one year, reflecting significant price growth supported by improving business performance and increasing investor interest. Source https://www.screener.in/company/504346/  Impact of Corporate Actions on RRP Semiconductor Ltd Share Price While studying the share price movement of RRP Semiconductor, one should be aware of various corporate actions taken by the company.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of RRP Semiconductor Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, RRP Semiconductor Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of RRP Semiconductor Ltd is 10,959 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of RRP Semiconductor Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of RRP Semiconductor Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for RRP Semiconductor Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the RRP Semiconductor Ltd stock price is INR ₹8044.35. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of RRP Semiconductor Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of RRP Semiconductor Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.